2-CL-IB-MECA性質(zhì)、用途與生產(chǎn)工藝

用途

2-Cl-IB-MECA用作充當(dāng)A3腺苷受體選擇性核苷。

生物活性

Namodenoson (CF-102, 2-Cl-IB-MECA) 是一種口服生物利用的 A3 adenosine receptor (A3AR) 的選擇性激動(dòng)劑，Ki值為0.33 nM。Namodenoson 具有使PI3K/NF?κB/Wnt/β?catenin信號(hào)通路失調(diào)來介導(dǎo)的抗NASH作用。

靶點(diǎn)

Target	Value
A3AR (Cell-free assay)	0.33 nM(Ki)

2-CL-IB-MECA 上下游產(chǎn)品信息

上游原料

下游產(chǎn)品

2-CL-IB-MECA 試劑級(jí)價(jià)格

更新日期	產(chǎn)品編號(hào)	產(chǎn)品名稱	CAS編號(hào)	包裝	價(jià)格
2025/02/05	S0498	2-CL-IB-MECA Namodenoson (CF-102)	163042-96-4	5mg	1165.84元
2025/02/05	S0498	Namodenoson (CF-102)	163042-96-4	10mM (1mL in DMSO)	1270元

2-CL-IB-MECA 生產(chǎn)廠家

 

163042-96-4, 2-CL-IB-MECA 相關(guān)搜索:

• 抑制劑
• 生化試劑
• 醫(yī)藥原料
• 細(xì)胞生物學(xué)試劑
• 化學(xué)試劑
• C18H18ClIN6O4
• 化合物2-CL-IB-MECA,10 MM DMSO 溶液
• 2-CL-IB-MECA,A3激動(dòng)劑
• 納莫德森
• 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-尾-D-RIBOFURANURONAMIDE
• (2S,3S,4R,5R)-5-(2-氯-6-((3-碘苯)氨基)-9H-嘌呤-9-基)-3,4-二羥基-N-甲基四氫呋喃-2-甲酰胺
• 那莫諾生CF-102
• 化合物2-CL-IB-MECA
• 2-CL-IB-MECA游離態(tài)
• 1-[2-氯-6-[[(3-碘苯基)甲基]氨基]-9H-嘌呤-9-基]-1-脫氧-N-甲基-BETA-D-呋喃核糖酰胺 FU
• 2-氯-N6-(3-碘芐基)腺苷-5'-N-甲基脲酰胺
• A3ADENOSINE受體激動(dòng)劑(2-CL-IB-MECA)
• 氯-IB-MECA
• 1-[2-氯-6-[[(3-碘苯基)甲基]氨基]-9H-嘌呤-9-基]-1-脫氧-N-甲基-BETA-D-呋喃核糖酰胺
• 163042-96-4
• Adenosine A₃ Receptor Agonist, 2-Cl-IB-MECA
• Namodenoson, 10 mM in DMSO
• 1-?[2-?chloro-?6-?[[(3-?iodophenyl)?methyl]?amino]?-?9H-?purin-?9-?yl]?-?1-?deoxy-?N-?methyl-β-?D-?Ribofuranuronamide
• 163042-96-4
• CF-102
• Cl-IB-MECA
• Netazepide
• Namodenoson (2 Cl-IB-MECA
• (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
• Namodenoson CF102
• β-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-
• CF-102(2-Cl-IB-MECA)
• CF102 Namodenoson
• CF102; CF-102; CF 102; CL-IB-MECA; 2-CL-IB-MECA
• CS-649
• 2-Cl-IB-MECA (CF-102)
• CI-IB-MECA
• 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-D-ribofuranuronamide
• (2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)aMino)-9H-purin-9-yl)-3,4-dihydroxy-N-Methyltetrahydrofuran-2-carboxaMide
• b-D-RibofuranuronaMide,1-[2-chloro-6-[[(3-iodophenyl)Methyl]aMino]-9H-purin-9-yl]-1-deoxy-N-Methyl-
• 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-β-D-RIBOFURANURONAMIDE 2-Cl-IB-Meca
• 1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide
• Cl-IB-MECA, 2-Chloro-N6-(3-iodobenzyl)-adenosine-5μ-N-methyluronamide
• 1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-(9H)-purin-9-yl)-1-deoxy-N-methyl-beta-D-ribofuranuronamide
• 1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE
• 2-CL-IB-MECA